Contrary to common conceptions, bioreactors have more sophisticated analysis and control and with the advent of at-line analyzers more extensive opportunities than chemical reactors. The specialty chemical industry can get a preview of the future from the biopharmaceutical industry.
Terry Blevins gets around. In Monday's e-newsletter conference daily edition, we ran a video interview with Terry, and also Scott Broadley and Trish Benton of Broadley James Corporation. For those of you out in the cold in outer Ubangistan somewhere, Broadley James is one of the great names in wet chemistry.